Drug
R
R is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
60%
Ph phase_1
2
40%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (40.0%)
N/A3 (60.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Study of Felzartamab in Healthy Adult Subjects
NCT06285201
completednot_applicable
Masticatory Side-switch and Mixing Ability.
NCT05173259
completednot_applicable
Masticatory Side Change and Masticatory Function.
NCT04714437
completednot_applicable
Two Surgical Approaches for Root Coverage of Teeth Presenting Gingival Recession and Non-carious Cervical Lesion
NCT03341598
completedphase_1
Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337
NCT03793985
Clinical Trials (5)
Showing 5 of 5 trials
NCT06285201Phase 1
Study of Felzartamab in Healthy Adult Subjects
NCT05173259Not Applicable
Masticatory Side-switch and Mixing Ability.
NCT04714437Not Applicable
Masticatory Side Change and Masticatory Function.
NCT03341598Not Applicable
Two Surgical Approaches for Root Coverage of Teeth Presenting Gingival Recession and Non-carious Cervical Lesion
NCT03793985Phase 1
Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5